Across the UK, 12 million people have hearing loss and around 1 in 8 adults live with tinnitus. Despite this, there are not yet any clinically approved treatments or cures. We are determined to change this.
We support translational research – where promising discoveries move from the laboratory into clinical trials. Our Translational Research Initiative for Hearing (TRIH) initiative has four key components:
- working with partners
- engaging with patients.
Find out more about how we can help in each of these areas below. You can also email email@example.com for more information.